Uterus1.com: Great Information, Real Community, Better Living.
 Register
 Login
 Main Page
 Uterus News
Feature Story
 Education Center

Conditions
Treatments
Diagnostics

Find a Physician
HTA in the News
 Heavy Periods Center
sharonbober  Uterus
 Hero™

Dr. Sharon Bober:
Healing the Sex Lives of Cancer Patients
About Heroes
 Join the Discussion in  Our Forums
 Community
Uterus1 Forums
Patient Stories
Frequently
    Asked Questions

One Question Poll
    Archive

 Reference
Locate a Specialist
Online Resources
Uterus Anatomy
Video Library
Menstrual Diary
Office Visits
Patient Brochures
  
advertisement
Search the Body1 Network
April 21, 2019  
UTERINE NEWS: Feature Story

  • Print this Article
  • Email this Article
  • Antidepressants During Pregnancy

    Happy Mom, Sad Baby: Antidepressants During Pregnancy


    March 14, 2005

    By: Diana Barnes-Brown for Uterus1

    Recent research indicates that drugs used to treat depression, anxiety and other psychological disorders can be unsafe for pregnant women.

    The study from Spain indicates that the use of selective serotonin reuptake inhibitors (SSRIs) by pregnant women is connected to withdrawal symptoms in newborn babies.

    Dr. Emilio J. Sanz and fellow researchers at the University of La Laguna in Spain, together with collaborating researchers from the World Health Organization’s Collaborating Centre for International Drug Monitoring in Sweden, recently published their findings on expecting mothers’ use of SSRIs, a range of drugs popular for treating depression, anxiety, and other psychological or mood disorders.

    Since it is known that sudden breaks in SSRI drug regimens can lead to withdrawal symptoms, some of which may be severe, Sanz and his team examined the WHO’s medical database of adverse drug reactions, hoping to discover whether SSRI use in pregnant women might be connected to neonatal withdrawal syndrome.

    The research team noted that, “an association between paroxetine [the SSRI marketed under the brand name Paxil] as and neonatal convulsions was identified in December 2001, by the data-mining method routinely used to screen the WHO database of adverse drug reactions.”

    Trying to clarify the connection between SSRIs and such adverse reactions, the team searched for other cases of suspected SSRI withdrawal in newborns. They found that “a total of 93 cases of suspected SSRI-induced neonatal withdrawal syndrome had been reported” by November 2003, and that these cases were not limited to Paxil or paroxetine alone.

    While 64 of the cases were in fact associated with paroxetine, 16 were associated with fluoxetine (the drug in Lilly’s Prozac), nine were associated with sertaline (marketed by Pfizer under the brand name Zoloft), and seven were associated with citalopram (sold as Celexa by Lundbeck).

    While more research is called for to help doctors and scientists better understand the connection between SSRI use and neonatal withdrawal. Sanz and his colleagues noted that the findings are certainly cause for concern among pregnant women and their caregivers. “The team concluded that SSRIs, especially paroxetine, should be cautiously managed in the treatment of pregnant women with a psychiatric disorder,” noted the researchers.


    Last updated: 14-Mar-05

    Comments

  • Add Comment
  •    
    Interact on Uterus1

    Discuss this topic with others.
     
    Feature Archives

    Breast Milk as Nutrition and Medication for Critically Ill Infants

    Study Finds New Moms Still Excessively Sleepy After Four Months

    Preterm Infants and Their Mothers Benefit from Maternal Singing During Skin-to-Skin Contact

    Stress Impacts Ability to Get Pregnant

    Link Discovered Between Bacteria and Premature Water Breaking

    Next 5 Features ...

    More Features ...
       
     
    Related Multimedia

    Interview with James Spies, M.D. - The Effects of Less Functioning Vaults

    Interview with James Spies, M.D. about Treatments for Fibroids

    Dr. Schneller Interview Question: Are most of your patients long term patients?

    More Features ...
     
    Related Content
    Higher Doses of Drug Oxytocin Okay for Labor Augmentation, Say Researchers

    In Vitro Fertilization (IVF) Success Rates Vary By Race

    Birth Rates On the Rise in Older Women

    New Guidelines Assess Pregnancy and Asthma

    Drugs May Reduce Mom-To-Baby AIDS

    More Features ...
     
    Home About Us Press Jobs Advertise With Us Contact Us
    advertisement
    © 2019 Body1 All rights reserved.
    Disclaimer: The information provided within this website is for educational purposes only and is not a substitute for consultation with your physician or healthcare provider. The opinions expressed herein are not necessarily those of the Owners and Sponsors of this site. By using this site you agree to indemnify, and hold the Owners and Sponsors harmless, from any disputes arising from content posted here-in.